Vol.

No.

July 28, 2017Jul 28, 2017

DOWNLOAD THE PDF

$Pediatric MATCH starts to accrue children with recurrent and refractory cancers$

Cover Story

Pediatric MATCH starts to accrue children with recurrent and refractory cancers

NCI and the Children's Oncology Group opened enrollment in Pediatric Molecular Analysis for Therapy Choice—Pediatric MATCH—a long-awaited precision medicine trial.

Conversation with The Cancer Letter

Will Parsons: This is a fantastic opportunity to test precision oncology for pediatric patients in a large-scale way

By Paul Goldberg

Conversation with The Cancer Letter Free

Rita Redberg: FDA proposal to delay reporting of device malfunctions “should be tossed”

By Matthew Bin Han Ong

Pediatric MATCH starts to accrue children with recurrent and refractory cancers

Will Parsons: This is a fantastic opportunity to test precision oncology for pediatric patients in a large-scale way

Rita Redberg: FDA proposal to delay reporting of device malfunctions “should be tossed”

In Brief

Carlos Arteaga to head UT Southwestern Simmons Comprehensive Cancer Center

Larry Copeland appointed president of GOG Foundation

Edith Mitchell receives 2017 ASTRO Honorary Membership

SU2C-Lustgarten Foundation team aims to apply CAR T-cell therapy to pancreatic cancer

Andrew Baschnagel wins UW Carbone Cancer Center award for lung cancer study

Cancer groups release statement on health disparities research

Report shows cancer patients struggle to afford treatment

Christiana Care Gene Editing Institute, NovellusDx form personalized medicine partnership

Drugs & Targets

FDA expands approval of Yervoy to include pediatric patients 12 years and older with unresectable or metastatic melanoma

FDA accepts BMS applications for Opdivo four-week dosing schedule across approved indications

Novartis receives positive CHMP opinion for Rydapt for newly diagnosed FLT3-mutated AML, three types of advanced systemic mastocytosis

AstraZeneca and Merck from oncology collaboration

CHMP issues positive opinion for avelumab for metastatic Merkel cell carcinoma

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login